Brain Aneurysm Clinical Trials

Find Brain Aneurysm Clinical Trials Near You

Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms

Status: Recruiting
Location: See all (26) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of the bCAN study is to create a prospective collection of multimodal data and human samples, linked to the French Intracranial Aneurysm Registry (FRAN). The aim of bCAN is to enable risk stratification of ruptured ICAs by redefining intracranial aneurysm disease. The description of genotypically and phenotypically specific subgroups of cases will pave the way for improved patient management based on new diagnostic/prognostic strategies among AIC carriers, either in a familial context, or at the level of the general population.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Any adult patient consulting for a definite and typical bifurcation AIC authenticated on MRI and/or cerebral arteriography

• Aneurysm discovered less than a year ago, with initial imaging (MRI and/or CTA and DSA) available

• Written consent obtained for study participation

• Patient covered by a social security plan

• Index case: Any adult patient consulting for a definite and typical bifurcation ICA presenting at least one other case with ICA related (child, parent, brother, sister) detected by MRI with at least one Time of Flight (TOF) sequence.

• Family relatives: children, parents, brothers, sisters, of legal age, of patients with a family history of definite, typical bifurcation AIC (≥ 4 affected), Screening to be performed using MRI with at least a Time of Flight (TOF) sequence.

• Written consent to participate in the study

• Patient and relatives covered by a social security plan

Locations
Other Locations
France
CHU Amiens
NOT_YET_RECRUITING
Amiens
CHU Angers
NOT_YET_RECRUITING
Angers
CHU Besançon
NOT_YET_RECRUITING
Besançon
CHU Bordeaux Hôpital Pellegrin
NOT_YET_RECRUITING
Bordeaux
CHU de Brest
NOT_YET_RECRUITING
Brest
CHU Caen-Normandie
NOT_YET_RECRUITING
Caen
CHU Clermont-Ferrand
RECRUITING
Clermont-ferrand
CHU Limoges
NOT_YET_RECRUITING
Limoges
APHM
NOT_YET_RECRUITING
Marseille
CHU de Montpellier
NOT_YET_RECRUITING
Montpellier
CHRU de Nancy
NOT_YET_RECRUITING
Nancy
Nantes University Hospital
RECRUITING
Nantes
GHU Paris - Hôpital Ste Anne
NOT_YET_RECRUITING
Paris
Hôpital Fondation Rothschild
NOT_YET_RECRUITING
Paris
Hôpital La Pitié Salpêtrière
NOT_YET_RECRUITING
Paris
Hôpital Lariboisière
NOT_YET_RECRUITING
Paris
CHU de Poitiers
NOT_YET_RECRUITING
Poitiers
CHU de Reims
NOT_YET_RECRUITING
Reims
CHU Rennes
NOT_YET_RECRUITING
Rennes
CHU de Rouen
NOT_YET_RECRUITING
Rouen
CHU St Etienne
NOT_YET_RECRUITING
Saint-etienne
Hôpitaux Universitaires de Strasbourg
NOT_YET_RECRUITING
Strasbourg
Hôpital Foch
NOT_YET_RECRUITING
Suresnes
HIA Sainte-Anne
NOT_YET_RECRUITING
Toulon
CHU de Toulouse
NOT_YET_RECRUITING
Toulouse
CHRU Tours Hôpital Bretonneau
NOT_YET_RECRUITING
Tours
Contact Information
Primary
Romain BOURCIER, MD
romain.bourcier@chu-nantes.fr
33240165608
Time Frame
Start Date: 2025-03-25
Estimated Completion Date: 2027-03-25
Participants
Target number of participants: 1100
Treatments
Other: ICA cases
Any adult patient consulting for a definite and typical bifurcation AIC authenticated on MRI and/or cerebral arteriography
Related Therapeutic Areas
Sponsors
Leads: Nantes University Hospital
Collaborators: Federation of Medical Specialties

This content was sourced from clinicaltrials.gov